Antimicrobial susceptibility of Helicobacter pylori isolates in Smolensk in 2015-2016

Aim of investigation. To determine antimicrobial susceptibility of H. pylori in Smolensk in 2015-2016. Material and methods. Overall 248 adult patients with positive rapid urease test at the time of gastroscopy were included in the study. Antimicrobial susceptibility testing of H. pylori isolates to...

Full description

Saved in:
Bibliographic Details
Main Authors: N. N. Dekhnich, N. V. Ivanchik, R. S. Kozlov, A. V. Alimov, A. V. Lukyanova, O. A. Nagaeva, A. S. Steshits, P. G. Bruk
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/93
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860293021728768
author N. N. Dekhnich
N. V. Ivanchik
R. S. Kozlov
A. V. Alimov
A. V. Lukyanova
O. A. Nagaeva
A. S. Steshits
P. G. Bruk
author_facet N. N. Dekhnich
N. V. Ivanchik
R. S. Kozlov
A. V. Alimov
A. V. Lukyanova
O. A. Nagaeva
A. S. Steshits
P. G. Bruk
author_sort N. N. Dekhnich
collection DOAJ
description Aim of investigation. To determine antimicrobial susceptibility of H. pylori in Smolensk in 2015-2016. Material and methods. Overall 248 adult patients with positive rapid urease test at the time of gastroscopy were included in the study. Antimicrobial susceptibility testing of H. pylori isolates to clarithromycin, amoxicillin, metronidazole, levofloxacin, rifampicin, tetracycline was performed by the agar dilution method. Results. H. pylori was isolated in 33% (n=82) of patients (24 isolates were nonviable after freezing). The rates of resistance among tested isolates of H. pylori were: 3,5% (2/58) for clarithromycin, 3,5% (2/58) for amoxicillin, 10.3% (6/58) for metronidazole, 27,6% (16/58) for levofloxacin, 8.6% (5/58) for rifampicin. No isolates showed resistance to tetracycline. Among 58 H. pylori isolates 29% (17 isolates) were resistant to one antimicrobial agent, 12,1% (7 isolates) were resistant to two antimicrobial agents. Associated resistance was observed for levofloxacin and metronidazole 3,5% (2 isolates), levofloxacin and rifampicin 5,2% (3 isolates), metronidazole and rifampicin 3,5% (2 isolates). Conclusions. Smolensk is the area of low clarithromycin resistance. So, clarithromycin-containing regimens are recommended for first-line empirical eradication therapy. Use of levofloxacin is questionable in relation to high levels of resistance H. pylori to levofloxacin. Use of rifabutin is questionable in relation to relatively high H. pylori rifampicin resistance rate.
format Article
id doaj-art-86937e14a9bc44fb9fd9d75e0e28ec4e
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2018-08-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-86937e14a9bc44fb9fd9d75e0e28ec4e2025-02-10T16:14:28ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-01266243110.22416/1382-4376-2016-6-24-3193Antimicrobial susceptibility of Helicobacter pylori isolates in Smolensk in 2015-2016N. N. Dekhnich0N. V. Ivanchik1R. S. Kozlov2A. V. Alimov3A. V. Lukyanova4O. A. Nagaeva5A. S. Steshits6P. G. Bruk7Federal state educational government financed institution higher education «Smolensk State Medical University»Federal state educational government financed institution higher education «Smolensk State Medical University»Federal state educational government financed institution higher education «Smolensk State Medical University»«Clinical Hospital № 1»«Clinical Hospital № 1»«Clinical Hospital № 1»«Smolensk Regional Clinical Hospital»«Smolensk Regional Clinical Hospital»Aim of investigation. To determine antimicrobial susceptibility of H. pylori in Smolensk in 2015-2016. Material and methods. Overall 248 adult patients with positive rapid urease test at the time of gastroscopy were included in the study. Antimicrobial susceptibility testing of H. pylori isolates to clarithromycin, amoxicillin, metronidazole, levofloxacin, rifampicin, tetracycline was performed by the agar dilution method. Results. H. pylori was isolated in 33% (n=82) of patients (24 isolates were nonviable after freezing). The rates of resistance among tested isolates of H. pylori were: 3,5% (2/58) for clarithromycin, 3,5% (2/58) for amoxicillin, 10.3% (6/58) for metronidazole, 27,6% (16/58) for levofloxacin, 8.6% (5/58) for rifampicin. No isolates showed resistance to tetracycline. Among 58 H. pylori isolates 29% (17 isolates) were resistant to one antimicrobial agent, 12,1% (7 isolates) were resistant to two antimicrobial agents. Associated resistance was observed for levofloxacin and metronidazole 3,5% (2 isolates), levofloxacin and rifampicin 5,2% (3 isolates), metronidazole and rifampicin 3,5% (2 isolates). Conclusions. Smolensk is the area of low clarithromycin resistance. So, clarithromycin-containing regimens are recommended for first-line empirical eradication therapy. Use of levofloxacin is questionable in relation to high levels of resistance H. pylori to levofloxacin. Use of rifabutin is questionable in relation to relatively high H. pylori rifampicin resistance rate.https://www.gastro-j.ru/jour/article/view/93helicobacter pyloriрезистентность к антимикробным препаратамкларитромицинметронидазоламоксициллинлевофлоксацин
spellingShingle N. N. Dekhnich
N. V. Ivanchik
R. S. Kozlov
A. V. Alimov
A. V. Lukyanova
O. A. Nagaeva
A. S. Steshits
P. G. Bruk
Antimicrobial susceptibility of Helicobacter pylori isolates in Smolensk in 2015-2016
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
helicobacter pylori
резистентность к антимикробным препаратам
кларитромицин
метронидазол
амоксициллин
левофлоксацин
title Antimicrobial susceptibility of Helicobacter pylori isolates in Smolensk in 2015-2016
title_full Antimicrobial susceptibility of Helicobacter pylori isolates in Smolensk in 2015-2016
title_fullStr Antimicrobial susceptibility of Helicobacter pylori isolates in Smolensk in 2015-2016
title_full_unstemmed Antimicrobial susceptibility of Helicobacter pylori isolates in Smolensk in 2015-2016
title_short Antimicrobial susceptibility of Helicobacter pylori isolates in Smolensk in 2015-2016
title_sort antimicrobial susceptibility of helicobacter pylori isolates in smolensk in 2015 2016
topic helicobacter pylori
резистентность к антимикробным препаратам
кларитромицин
метронидазол
амоксициллин
левофлоксацин
url https://www.gastro-j.ru/jour/article/view/93
work_keys_str_mv AT nndekhnich antimicrobialsusceptibilityofhelicobacterpyloriisolatesinsmolenskin20152016
AT nvivanchik antimicrobialsusceptibilityofhelicobacterpyloriisolatesinsmolenskin20152016
AT rskozlov antimicrobialsusceptibilityofhelicobacterpyloriisolatesinsmolenskin20152016
AT avalimov antimicrobialsusceptibilityofhelicobacterpyloriisolatesinsmolenskin20152016
AT avlukyanova antimicrobialsusceptibilityofhelicobacterpyloriisolatesinsmolenskin20152016
AT oanagaeva antimicrobialsusceptibilityofhelicobacterpyloriisolatesinsmolenskin20152016
AT assteshits antimicrobialsusceptibilityofhelicobacterpyloriisolatesinsmolenskin20152016
AT pgbruk antimicrobialsusceptibilityofhelicobacterpyloriisolatesinsmolenskin20152016